Global Human Vaccines Administered Orally Market Growth 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Vaccines Administered Orally Consumption 2016-2026

2.1.2 Human Vaccines Administered Orally Consumption CAGR by Region

2.2 Human Vaccines Administered Orally Segment by Type

2.2.1 Rotavirus Vaccine

2.2.2 Cholera Vaccine

2.2.3 Oral Polio Vaccine

2.3 Human Vaccines Administered Orally Sales by Type

2.3.1 Global Human Vaccines Administered Orally Sales Market Share by Type (2016-2021)

2.3.2 Global Human Vaccines Administered Orally Revenue and Market Share by Type (2016-2021)

2.3.3 Global Human Vaccines Administered Orally Sale Price by Type (2016-2021)

2.4 Human Vaccines Administered Orally Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Human Vaccines Administered Orally Sales by Application

2.5.1 Global Human Vaccines Administered Orally Sale Market Share by Application (2016-2021)

2.5.2 Global Human Vaccines Administered Orally Revenue and Market Share by Application (2016-2021)

2.5.3 Global Human Vaccines Administered Orally Sale Price by Application (2016-2021)

3 Global Human Vaccines Administered Orally by Company

3.1 Global Human Vaccines Administered Orally Sales Market Share by Company

3.1.1 Global Human Vaccines Administered Orally Sales by Company (2019-2021)

3.1.2 Global Human Vaccines Administered Orally Sales Market Share by Company (2019-2021)

3.2 Global Human Vaccines Administered Orally Revenue Market Share by Company

3.2.1 Global Human Vaccines Administered Orally Revenue by Company (2019-2021)

3.2.2 Global Human Vaccines Administered Orally Revenue Market Share by Company (2019-2021)

3.3 Global Human Vaccines Administered Orally Sale Price by Company

3.4 Global Manufacturers Human Vaccines Administered Orally Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Vaccines Administered Orally Product Location Distribution

3.4.2 Players Human Vaccines Administered Orally Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Human Vaccines Administered Orally by Region

4.1 Global Human Vaccines Administered Orally by Region

4.1.1 Global Human Vaccines Administered Orally Sales by Region

4.1.2 Global Human Vaccines Administered Orally Revenue by Region

4.2 Americas Human Vaccines Administered Orally Sales Growth

4.3 APAC Human Vaccines Administered Orally Sales Growth

4.4 Europe Human Vaccines Administered Orally Sales Growth

4.5 Middle East & Africa Human Vaccines Administered Orally Sales Growth

5 Americas

5.1 Americas Human Vaccines Administered Orally Sales by Country

5.1.1 Americas Human Vaccines Administered Orally Sales by Country (2016-2021)

5.1.2 Americas Human Vaccines Administered Orally Revenue by Country (2016-2021)

5.2 Americas Human Vaccines Administered Orally Sales by Type

5.3 Americas Human Vaccines Administered Orally Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Vaccines Administered Orally Sales by Region

6.1.1 APAC Human Vaccines Administered Orally Sales by Region (2016-2021)

6.1.2 APAC Human Vaccines Administered Orally Revenue by Region (2016-2021)

6.2 APAC Human Vaccines Administered Orally Sales by Type

6.3 APAC Human Vaccines Administered Orally Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Human Vaccines Administered Orally by Country

7.1.1 Europe Human Vaccines Administered Orally Sales by Country (2016-2021)

7.1.2 Europe Human Vaccines Administered Orally Revenue by Country (2016-2021)

7.2 Europe Human Vaccines Administered Orally Sales by Type

7.3 Europe Human Vaccines Administered Orally Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Vaccines Administered Orally by Country

8.1.1 Middle East & Africa Human Vaccines Administered Orally Sales by Country (2016-2021)

8.1.2 Middle East & Africa Human Vaccines Administered Orally Revenue by Country (2016-2021)

8.2 Middle East & Africa Human Vaccines Administered Orally Sales by Type

8.3 Middle East & Africa Human Vaccines Administered Orally Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Human Vaccines Administered Orally Distributors

10.3 Human Vaccines Administered Orally Customer

11 Global Human Vaccines Administered Orally Market Forecast

11.1 Global Human Vaccines Administered Orally Forecast by Region

11.1.1 Global Human Vaccines Administered Orally Forecast by Regions (2021-2026)

11.2.2 Global Human Vaccines Administered Orally Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Human Vaccines Administered Orally Forecast by Type

11.7 Global Human Vaccines Administered Orally Forecast by Application

12 Key Players Analysis

12.1 Merck

12.1.1 Merck Company Information

12.1.2 Merck Human Vaccines Administered Orally Product Offered

12.1.3 Merck Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Merck Main Business Overview

12.1.5 Merck Latest Developments

12.2 GSK

12.2.1 GSK Company Information

12.2.2 GSK Human Vaccines Administered Orally Product Offered

12.2.3 GSK Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 GSK Main Business Overview

12.2.5 GSK Latest Developments

12.3 Sanofi

12.3.1 Sanofi Company Information

12.3.2 Sanofi Human Vaccines Administered Orally Product Offered

12.3.3 Sanofi Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Sanofi Main Business Overview

12.3.5 Sanofi Latest Developments

12.4 Lanzhou Institute

12.4.1 Lanzhou Institute Company Information

12.4.2 Lanzhou Institute Human Vaccines Administered Orally Product Offered

12.4.3 Lanzhou Institute Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Lanzhou Institute Main Business Overview

12.4.5 Lanzhou Institute Latest Developments

12.5 Serum Institute

12.5.1 Serum Institute Company Information

12.5.2 Serum Institute Human Vaccines Administered Orally Product Offered

12.5.3 Serum Institute Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Serum Institute Main Business Overview

12.5.5 Serum Institute Latest Developments

12.6 Valneva

12.6.1 Valneva Company Information

12.6.2 Valneva Human Vaccines Administered Orally Product Offered

12.6.3 Valneva Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Valneva Main Business Overview

12.6.5 Valneva Latest Developments

12.7 Shanghai United Cell

12.7.1 Shanghai United Cell Company Information

12.7.2 Shanghai United Cell Human Vaccines Administered Orally Product Offered

12.7.3 Shanghai United Cell Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Shanghai United Cell Main Business Overview

12.7.5 Shanghai United Cell Latest Developments

12.8 Bibcol

12.8.1 Bibcol Company Information

12.8.2 Bibcol Human Vaccines Administered Orally Product Offered

12.8.3 Bibcol Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Bibcol Main Business Overview

12.8.5 Bibcol Latest Developments

12.9 PaxVax

12.9.1 PaxVax Company Information

12.9.2 PaxVax Human Vaccines Administered Orally Product Offered

12.9.3 PaxVax Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 PaxVax Main Business Overview

12.9.5 PaxVax Latest Developments

12.10 Vabiotech

12.10.1 Vabiotech Company Information

12.10.2 Vabiotech Human Vaccines Administered Orally Product Offered

12.10.3 Vabiotech Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Vabiotech Main Business Overview

12.10.5 Vabiotech Latest Developments

12.11 Tiantan Biological

12.11.1 Tiantan Biological Company Information

12.11.2 Tiantan Biological Human Vaccines Administered Orally Product Offered

12.11.3 Tiantan Biological Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Tiantan Biological Main Business Overview

12.11.5 Tiantan Biological Latest Developments

12.12 EuBiologics

12.12.1 EuBiologics Company Information

12.12.2 EuBiologics Human Vaccines Administered Orally Product Offered

12.12.3 EuBiologics Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 EuBiologics Main Business Overview

12.12.5 EuBiologics Latest Developments

12.13 Panacea Biotec Ltd

12.13.1 Panacea Biotec Ltd Company Information

12.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Product Offered

12.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Panacea Biotec Ltd Main Business Overview

12.13.5 Panacea Biotec Ltd Latest Developments

12.14 Bio-Med

12.14.1 Bio-Med Company Information

12.14.2 Bio-Med Human Vaccines Administered Orally Product Offered

12.14.3 Bio-Med Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Bio-Med Main Business Overview

12.14.5 Bio-Med Latest Developments

12.15 Halfkin Bio-Pharmaceuticals

12.15.1 Halfkin Bio-Pharmaceuticals Company Information

12.15.2 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Offered

12.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview

12.15.5 Halfkin Bio-Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

Table 1. Human Vaccines Administered Orally Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Rotavirus Vaccine

Table 3. Major Players of Cholera Vaccine

Table 4. Major Players of Oral Polio Vaccine

Table 5. Global Human Vaccines Administered Orally Sales by Type (2016-2021) & (K Units)

Table 6. Global Human Vaccines Administered Orally Sales Market Share by Type (2016-2021)

Table 7. Global Human Vaccines Administered Orally Revenue by Type (2016-2021) & ($ million)

Table 8. Global Human Vaccines Administered Orally Revenue Market Share by Type (2016-2021)

Table 9. Global Human Vaccines Administered Orally Sale Price by Type (2016-2021)

Table 10. Global Human Vaccines Administered Orally Sales by Application (2016-2021) & (K Units)

Table 11. Global Human Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Table 12. Global Human Vaccines Administered Orally Value by Application (2016-2021)

Table 13. Global Human Vaccines Administered Orally Revenue Market Share by Application (2016-2021)

Table 14. Global Human Vaccines Administered Orally Sale Price by Application (2016-2021)

Table 15. Global Human Vaccines Administered Orally Sales by Company (2019-2021) & (K Units)

Table 16. Global Human Vaccines Administered Orally Sales Market Share by Company (2019-2021)

Table 17. Global Human Vaccines Administered Orally Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Human Vaccines Administered Orally Revenue Market Share by Company (2019-2021)

Table 19. Global Human Vaccines Administered Orally Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Human Vaccines Administered Orally Producing Area Distribution and Sales Area

Table 21. Players Human Vaccines Administered Orally Products Offered

Table 22. Human Vaccines Administered Orally Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Human Vaccines Administered Orally Sales by Region (2016-2021) (K Units)

Table 26. Global Human Vaccines Administered Orally Sales Market Share by Region (2016-2021)

Table 27. Global Human Vaccines Administered Orally Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Human Vaccines Administered Orally Revenue Market Share by Region (2016-2021)

Table 29. Americas Human Vaccines Administered Orally Sales by Country (2016-2021) & (K Units)

Table 30. Americas Human Vaccines Administered Orally Sales Market Share by Country (2016-2021)

Table 31. Americas Human Vaccines Administered Orally Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Human Vaccines Administered Orally Revenue Market Share by Country (2016-2021)

Table 33. Americas Human Vaccines Administered Orally Sales by Type (2016-2021) & (K Units)

Table 34. Americas Human Vaccines Administered Orally Sales Market Share by Type (2016-2021)

Table 35. Americas Human Vaccines Administered Orally Sales by Application (2016-2021) & (K Units)

Table 36. Americas Human Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Table 37. APAC Human Vaccines Administered Orally Sales by Region (2016-2021) & (K Units)

Table 38. APAC Human Vaccines Administered Orally Sales Market Share by Region (2016-2021)

Table 39. APAC Human Vaccines Administered Orally Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Human Vaccines Administered Orally Revenue Market Share by Region (2016-2021)

Table 41. APAC Human Vaccines Administered Orally Sales by Type (2016-2021) & (K Units)

Table 42. APAC Human Vaccines Administered Orally Sales Market Share by Type (2016-2021)

Table 43. APAC Human Vaccines Administered Orally Sales by Application (2016-2021) & (K Units)

Table 44. APAC Human Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Table 45. Europe Human Vaccines Administered Orally Sales by Country (2016-2021) & (K Units)

Table 46. Europe Human Vaccines Administered Orally Sales Market Share by Country (2016-2021)

Table 47. Europe Human Vaccines Administered Orally Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Human Vaccines Administered Orally Revenue Market Share by Country (2016-2021)

Table 49. Europe Human Vaccines Administered Orally Sales by Type (2016-2021) & (K Units)

Table 50. Europe Human Vaccines Administered Orally Sales Market Share by Type (2016-2021)

Table 51. Europe Human Vaccines Administered Orally Sales by Application (2016-2021) & (K Units)

Table 52. Europe Human Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Human Vaccines Administered Orally Sales by Country (2016-2021) & (K Units)

Table 54. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Human Vaccines Administered Orally Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Human Vaccines Administered Orally Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Human Vaccines Administered Orally Sales by Type (2016-2021) & (K Units)

Table 58. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Human Vaccines Administered Orally Sales by Application (2016-2021) & (K Units)

Table 60. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Table 61. Key and Potential Regions of Human Vaccines Administered Orally

Table 62. Key Application and Potential Industries of Human Vaccines Administered Orally

Table 63. Key Challenges of Human Vaccines Administered Orally

Table 64. Key Trends of Human Vaccines Administered Orally

Table 65. Human Vaccines Administered Orally Distributors List

Table 66. Human Vaccines Administered Orally Customer List

Table 67. Global Human Vaccines Administered Orally Sales Forecast by Region (2021-2026) & (K Units)

Table 68. Global Human Vaccines Administered Orally Consumption Market Forecast by Region

Table 69. Global Human Vaccines Administered Orally Revenue Forecast by Region (2021-2026) & ($ millions)

Table 70. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Region (2021-2026)

Table 71. Americas Human Vaccines Administered Orally Sales Forecast by Country (2021-2026) & (K Units)

Table 72. Americas Human Vaccines Administered Orally Revenue Forecast by Country (2021-2026) & ($ millions)

Table 73. APAC Human Vaccines Administered Orally Sales Forecast by Region (2021-2026) & (K Units)

Table 74. APAC Human Vaccines Administered Orally Revenue Forecast by Region (2021-2026) & ($ millions)

Table 75. Europe Human Vaccines Administered Orally Sales Forecast by Country (2021-2026) & (K Units)

Table 76. Europe Human Vaccines Administered Orally Revenue Forecast by Country (2021-2026) & ($ millions)

Table 77. Middle East & Africa Human Vaccines Administered Orally Sales Forecast by Country (2021-2026) & (K Units)

Table 78. Middle East & Africa Human Vaccines Administered Orally Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Global Human Vaccines Administered Orally Sales Forecast by Type (2021-2026) & (K Units)

Table 80. Global Human Vaccines Administered Orally Sales Market Share Forecast by Type (2021-2026)

Table 81. Global Human Vaccines Administered Orally Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 82. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Type (2021-2026)

Table 83. Global Human Vaccines Administered Orally Sales Forecast by Application (2021-2026) & (K Units)

Table 84. Global Human Vaccines Administered Orally Sales Market Share Forecast by Application (2021-2026)

Table 85. Global Human Vaccines Administered Orally Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 86. Global Human Vaccines Administered Orally Revenue Market Share Forecast by Application (2021-2026)

Table 87. Merck Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 88. Merck Human Vaccines Administered Orally Product Offered

Table 89. Merck Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 90. Merck Main Business

Table 91. Merck Latest Developments

Table 92. GSK Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 93. GSK Human Vaccines Administered Orally Product Offered

Table 94. GSK Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 95. GSK Main Business

Table 96. GSK Latest Developments

Table 97. Sanofi Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 98. Sanofi Human Vaccines Administered Orally Product Offered

Table 99. Sanofi Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 100. Sanofi Main Business

Table 101. Sanofi Latest Developments

Table 102. Lanzhou Institute Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 103. Lanzhou Institute Human Vaccines Administered Orally Product Offered

Table 104. Lanzhou Institute Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 105. Lanzhou Institute Main Business

Table 106. Lanzhou Institute Latest Developments

Table 107. Serum Institute Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 108. Serum Institute Human Vaccines Administered Orally Product Offered

Table 109. Serum Institute Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 110. Serum Institute Main Business

Table 111. Serum Institute Latest Developments

Table 112. Valneva Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 113. Valneva Human Vaccines Administered Orally Product Offered

Table 114. Valneva Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 115. Valneva Main Business

Table 116. Valneva Latest Developments

Table 117. Shanghai United Cell Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 118. Shanghai United Cell Human Vaccines Administered Orally Product Offered

Table 119. Shanghai United Cell Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 120. Shanghai United Cell Main Business

Table 121. Shanghai United Cell Latest Developments

Table 122. Bibcol Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 123. Bibcol Human Vaccines Administered Orally Product Offered

Table 124. Bibcol Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 125. Bibcol Main Business

Table 126. Bibcol Latest Developments

Table 127. PaxVax Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 128. PaxVax Human Vaccines Administered Orally Product Offered

Table 129. PaxVax Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 130. PaxVax Main Business

Table 131. PaxVax Latest Developments

Table 132. Vabiotech Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 133. Vabiotech Human Vaccines Administered Orally Product Offered

Table 134. Vabiotech Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 135. Vabiotech Main Business

Table 136. Vabiotech Latest Developments

Table 137. Tiantan Biological Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 138. Tiantan Biological Human Vaccines Administered Orally Product Offered

Table 139. Tiantan Biological Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 140. Tiantan Biological Main Business

Table 141. Tiantan Biological Latest Developments

Table 142. EuBiologics Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 143. EuBiologics Human Vaccines Administered Orally Product Offered

Table 144. EuBiologics Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 145. EuBiologics Main Business

Table 146. EuBiologics Latest Developments

Table 147. Panacea Biotec Ltd Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 148. Panacea Biotec Ltd Human Vaccines Administered Orally Product Offered

Table 149. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 150. Panacea Biotec Ltd Main Business

Table 151. Panacea Biotec Ltd Latest Developments

Table 152. Bio-Med Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 153. Bio-Med Human Vaccines Administered Orally Product Offered

Table 154. Bio-Med Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 155. Bio-Med Main Business

Table 156. Bio-Med Latest Developments

Table 157. Halfkin Bio-Pharmaceuticals Basic Information, Human Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors

Table 158. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Offered

Table 159. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 160. Halfkin Bio-Pharmaceuticals Main Business

Table 161. Halfkin Bio-Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Human Vaccines Administered Orally

Figure 2. Human Vaccines Administered Orally Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Vaccines Administered Orally Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Human Vaccines Administered Orally Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Human Vaccines Administered Orally Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Rotavirus Vaccine

Figure 10. Product Picture of Cholera Vaccine

Figure 11. Product Picture of Oral Polio Vaccine

Figure 12. Global Human Vaccines Administered Orally Sales Market Share by Type in 2020

Figure 13. Global Human Vaccines Administered Orally Revenue Market Share by Type (2016-2021)

Figure 14. Human Vaccines Administered Orally Consumed in Public

Figure 15. Global Human Vaccines Administered Orally Market: Public (2016-2021) & (K Units)

Figure 16. Human Vaccines Administered Orally Consumed in Private

Figure 17. Global Human Vaccines Administered Orally Market: Private (2016-2021) & (K Units)

Figure 18. Global Human Vaccines Administered Orally Sales Market Share by Application (2016-2021)

Figure 19. Global Human Vaccines Administered Orally Revenue Market Share by Application in 2020

Figure 20. Human Vaccines Administered Orally Revenue Market by Company in 2020 ($ Million)

Figure 21. Global Human Vaccines Administered Orally Revenue Market Share by Company in 2020

Figure 22. Global Human Vaccines Administered Orally Sales Market Share by Regions (2016-2021)

Figure 23. Global Human Vaccines Administered Orally Revenue Market Share by Region in 2020

Figure 24. Americas Human Vaccines Administered Orally Sales 2016-2021 (K Units)

Figure 25. Americas Human Vaccines Administered Orally Revenue 2016-2021 ($ Millions)

Figure 26. APAC Human Vaccines Administered Orally Sales 2016-2021 (K Units)

Figure 27. APAC Human Vaccines Administered Orally Revenue 2016-2021 ($ Millions)

Figure 28. Europe Human Vaccines Administered Orally Sales 2016-2021 (K Units)

Figure 29. Europe Human Vaccines Administered Orally Revenue 2016-2021 ($ Millions)

Figure 30. Middle East & Africa Human Vaccines Administered Orally Sales 2016-2021 (K Units)

Figure 31. Middle East & Africa Human Vaccines Administered Orally Revenue 2016-2021 ($ Millions)

Figure 32. Americas Human Vaccines Administered Orally Sales Market Share by Country in 2020

Figure 33. Americas Human Vaccines Administered Orally Revenue Market Share by Country in 2020

Figure 34. Americas Human Vaccines Administered Orally Sales Market Share by Type in 2020

Figure 35. Americas Human Vaccines Administered Orally Sales Market Share by Application in 2020

Figure 36. United States Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 37. Canada Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 38. Mexico Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 39. Brazil Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 40. APAC Human Vaccines Administered Orally Sales Market Share by Region in 2020

Figure 41. APAC Human Vaccines Administered Orally Revenue Market Share by Regions in 2020

Figure 42. APAC Human Vaccines Administered Orally Sales Market Share by Type in 2020

Figure 43. APAC Human Vaccines Administered Orally Sales Market Share by Application in 2020

Figure 44. China Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 45. Japan Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 46. Korea Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 47. Southeast Asia Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 48. India Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 49. Australia Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 50. Europe Human Vaccines Administered Orally Sales Market Share by Country in 2020

Figure 51. Europe Human Vaccines Administered Orally Revenue Market Share by Country in 2020

Figure 52. Europe Human Vaccines Administered Orally Sales Market Share by Type in 2020

Figure 53. Europe Human Vaccines Administered Orally Sales Market Share by Application in 2020

Figure 54. Germany Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 55. France Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 56. UK Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 57. Italy Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 58. Russia Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 59. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Country in 2020

Figure 60. Middle East & Africa Human Vaccines Administered Orally Revenue Market Share by Country in 2020

Figure 61. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Type in 2020

Figure 62. Middle East & Africa Human Vaccines Administered Orally Sales Market Share by Application in 2020

Figure 63. Egypt Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 64. South Africa Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 65. Israel Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 66. Turkey Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 67. GCC Country Human Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles